Occudo Quantitative Strategies LP Invests $229,000 in Premier, Inc. (NASDAQ:PINC)

Occudo Quantitative Strategies LP bought a new position in shares of Premier, Inc. (NASDAQ:PINC - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 10,825 shares of the company's stock, valued at approximately $229,000.

A number of other large investors have also modified their holdings of PINC. Barclays PLC raised its stake in shares of Premier by 32.2% during the 3rd quarter. Barclays PLC now owns 154,128 shares of the company's stock worth $3,081,000 after buying an additional 37,551 shares in the last quarter. Assenagon Asset Management S.A. increased its stake in Premier by 109.8% in the 4th quarter. Assenagon Asset Management S.A. now owns 468,524 shares of the company's stock valued at $9,933,000 after purchasing an additional 245,239 shares in the last quarter. Brooklyn Investment Group increased its stake in Premier by 61,750.0% in the 4th quarter. Brooklyn Investment Group now owns 1,237 shares of the company's stock valued at $26,000 after purchasing an additional 1,235 shares in the last quarter. Kera Capital Partners Inc. purchased a new position in Premier in the 4th quarter valued at approximately $248,000. Finally, Aaron Wealth Advisors LLC purchased a new position in Premier in the 4th quarter valued at approximately $220,000. 74.41% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Premier

In other Premier news, General Counsel David L. Klatsky sold 10,000 shares of the stock in a transaction on Wednesday, April 2nd. The stock was sold at an average price of $19.53, for a total transaction of $195,300.00. Following the sale, the general counsel now owns 90,597 shares in the company, valued at approximately $1,769,359.41. This represents a 9.94% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In the last 90 days, insiders have sold 22,119 shares of company stock worth $464,974. 0.96% of the stock is owned by insiders.

Premier Price Performance

NASDAQ:PINC traded down $0.14 during trading hours on Friday, reaching $23.06. 1,190,505 shares of the company traded hands, compared to its average volume of 1,246,230. The firm's 50-day moving average is $20.48 and its 200-day moving average is $20.73. The stock has a market cap of $1.90 billion, a P/E ratio of -230.58 and a beta of 0.54. Premier, Inc. has a 1-year low of $17.23 and a 1-year high of $23.56.

Premier Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Sunday, June 15th. Shareholders of record on Sunday, June 1st will be issued a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a yield of 3.64%. The ex-dividend date of this dividend is Friday, May 30th. Premier's dividend payout ratio (DPR) is presently 147.37%.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on PINC shares. Canaccord Genuity Group raised their price objective on Premier from $19.00 to $22.00 and gave the company a "hold" rating in a research note on Thursday, May 8th. Robert W. Baird raised their price objective on Premier from $19.00 to $22.00 and gave the company a "neutral" rating in a research note on Thursday, May 15th. Finally, Piper Sandler raised their price objective on Premier from $19.00 to $24.00 and gave the company a "neutral" rating in a research note on Wednesday. Seven equities research analysts have rated the stock with a hold rating, According to data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus price target of $22.20.

Premier Profile

Premier, Inc, together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and workforce solutions.